ENDRA Life Sciences Inc. (NDRA): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2023-03-16. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

1.18M
As of 2025-12-31
1.50M
As of 2026-06-30
-28.1%
3-year compound annual growth
34.05M2016-12-31: 723.3K2017-12-31: 3.92M2018-12-31: 7.42M2019-12-31: 8.42M2020-12-31: 34.05M2021-12-31: 2.13M2022-12-31: 3.17M2023-12-31: 5.9K2024-12-31: 536.9K2025-12-31: 1.18M1.18M
2016-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-311.18M+119.1%2026-03-31, Balance as of period end
2024-12-31536.9Kn/m2026-03-31, Balance as of period end
2023-12-315.9K-99.8%2025-04-07, Balance as of period end
2022-12-313.17Mn/c2024-03-28, Balance as of period end
2021-12-312.13Mn/c2023-03-16, Balance as of period end
2020-12-3134.05Mn/c2022-03-30, Balance as of period end
2019-12-318.42M+13.5%2021-03-25, Balance as of period end
2018-12-317.42M+89.2%2020-03-26, Balance as of period end
2017-12-313.92M+442.4%2019-03-11, Balance as of period end
2016-12-31723.3Kn/a2018-03-20, Balance as of period end